Navigation Links
RMANJ Research Demonstrates That Egg Freezing Prior To IVF Yields Positive Outcomes Without Increasing Risk Of Aneuploidy
Date:9/12/2012

BASKING RIDGE, N.J., Sept. 12, 2012 /PRNewswire/ -- A new study conducted by Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) has shown that transferable embryos after oocyte vitrification (egg freezing) have similar chances of culminating in pregnancy as those derived from fresh oocytes without increasing the risk of aneuploidy (abnormal number of chromosomes).  The findings appear in the September 2012 issue of Fertility & Sterility (Volume 98, Issue 3).

(Logo: http://photos.prnewswire.com/prnh/20120402/NY80340LOGO )

"This study provides an important piece of safety data that had been missing from the egg freezing story, namely that the embryos produced after vitrification are not at an increased risk of being chromosomally abnormal and are just as likely to implant and deliver healthy newborns," said Eric J. Forman, M.D., and lead investigator.  "Women who have to delay reproduction for a variety of reasons -- including prior to chemotherapy for cancer -- can for the first time do so with security, knowing that the embryos that develop later are just as likely to be normal.  With very high implantation rates, you don't need to transfer more embryos. These women can take advantage of all the benefits of single blastocyst transfer even if they are at an advanced reproductive age when they are ready to use the frozen oocytes."

"This study was the first well-controlled clinical trial of the impact of oocyte vitrification on embryo development and clinical outcome," said Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., founding partner of RMANJ.  "I congratulate lead investigator, Dr. Eric Forman and his collaborators on this outstanding research and contribution to Reproductive Endocrinology.  The implications for fertility preservation, oocyte donation, and possibly routine fertility
'/>"/>

SOURCE Reproductive Medicine Associates of New Jersey
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Global Laparoscopy Devices Market is Expected to Reach USD 13,152.9 Million in 2018: Transparency Market Research
2. AIT Bioscience Taps Ligand Binding Assay Expert Dr. Ron Bowsher as Senior Research Advisor
3. Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research
4. Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5. New Jersey Health Foundation Initiates Program To Spur Innovative Research
6. Vibrant Research Founder Dr. Pratheev Sreetharan Recipient of the TR35 Award from Technology Review Magazine
7. Researchers and Patient Advocates Honored with PhRMA Award
8. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
9. QYresearchReports.com - Global and China Synthesis Polypeptide Drug Industry 2012 Deep Research Report
10. Drug Discovery Technologies, BCC Research
11. European Market for Dental Instruments Surpasses $652 Million, According to New Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... REDWOOD CITY, Calif., March 19, 2012 Ingenuity Systems, ... life science researchers, today announced that the Weill Cornell ... iReport for use in its sequencing core facility.  Variant ... the output of whole genome and exome sequencing experiments ...
... 19, 2012  Johnson & Johnson (NYSE: JNJ) will provide ... parties on Monday, March 26th at approximately 10:30 ... College of Cardiology (ACC) Annual Scientific Sessions in ... of the EINSTEIN-PE study in treating patients with ...
Cached Medicine Technology:Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility 2
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... of awards in the 2007 Association TRENDS All-Media Contest, ... Society Magazine as well as the category won by ... honored at the Salute to Association Excellence event on ... the official publication of the Society for Biomolecular Sciences. ...
... the past two decades and is now second to back ... than men to suffer from persistent neck pain, in particular ... a computer keyboard. Previous studies have shown conflicting results as ... but there has not been enough high-quality research in this ...
... are looking for,that magic pill that will make us look and ... longer a pill, and nutrition trends of 2008 will,put you on ... all,the hype," said Dr. Clive R. Spray, a biochemist and leader ... can we improve the health of our family and ourselves?, ...
... are so many health,recommendations in the media these days that ... they can make for better,health in the year ahead. ISSA ... strong -- for their top,recommendations for the 10 best things ... ahead. Here are the results of that survey:, ...
... MCKINNEY, Texas, Jan. 4 Torchmark Corporation,(NYSE: ... two of its leading,insurance subsidiaries, United American Life ... from Delaware to Nebraska. Torchmark,plans to redomesticate other ... the premium tax rates in a number of ...
... DaVita Inc. (NYSE:,DVA) announced today that it and ... partnership to provide dialysis and vascular,access services, as ... the greater Phoenix area. The partnership will own ... to provide patients with,access to all available treatment ...
Cached Medicine News:Health News:Strength training of neck muscles relieves chronic pain 2Health News:Nutrition Trends of 2008 2Health News:Nutrition Trends of 2008 3Health News:Nutrition Trends of 2008 4Health News:International Sports Sciences Association's Ten Best Resolutions for Better Health in 2008 2
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Intended for the quantitative determination of alkaline phosphatase activity in serum or plasma. Kinetic reaction. 405 nm wavelength. 830 U/L at 30C linearity. Single vial, dry powder reagent....
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Medicine Products: